Table S3 from Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial
Thomas Graillon,Marc Sanson,Chantal Campello,Ahmed Idbaih,Matthieu Peyre,Hadrien Peyrière,Noémie Basset,Didier Autran,Catherine Roche,Michel Kalamarides,Pierre-Hugues Roche,Stéphane Fuentes,Emeline Tabouret,Maryline Barrie, Anita Cohen,Stéphane Honoré,Mohamed Boucekine,Karine Baumstarck,Dominique Figarella-Branger,Anne Barlier,Henry Dufour,Olivier Louis Chinot crossref（2023）
摘要
PFS6 and PFS12 depending of the in intention-to-treat or per protocole analyses as investigator or central review analyses.
查看译文
AI 理解论文
溯源树
样例
